Dysfunction of nonadrenergic noncholinergic inhibitory system after antigen inhalation in actively sensitized cat airways.
We have investigated whether proteases released during antigen inhalation cause dysfunction of the nonadrenergic noncholinergic inhibitory nervous system (NANCIS). Frequency-response (F-R) studies of NANCIS were performed before and after Ascaris antigen (ASC) inhalation using actively sensitized cats. NANC dilatatory effects were obtained by stimulating bilateral cervical vagi under cholinergic and beta-adrenergic blockade and serotonin-induced bronchoconstriction, and assessed by maximal percent relaxation (rmax) and the frequency causing 50% of maximal relaxation (EF50). ASC inhalation caused a transient increase in pulmonary resistance in all animals. One hour after ASC inhalation, pulmonary resistance returned to the baseline value, but ASC inhalation significantly attenuated NANC inhibitory activities: rmax decreased from 82.2 +/- 4.7 (mean +/- SE) to 64.3 +/- 11.2% (p less than 0.05), and the geometric mean of EF50 increased from 1.7 to 4.3 Hz (p less than 0.05). Dilatatory effects of infused VIP, a possible neurotransmitter of NANCIS, was also attenuated after ASC inhalation. Pretreatment with leupeptin (3 mg/kg) abolished ASC-induced impairment of NANC inhibitory activities. By contrast, dilatatory effects of adrenergic nerve stimulation were not affected by ASC inhalation. These results suggest that NANC inhibitory activities can be impaired after ASC inhalation, and that this impairment of NANCIS may be due to effects of proteases released during allergic reaction.
Miura
M
M
First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Ichinose
M
M
Kimura
K
K
Katsumata
U
U
Takahashi
T
T
Inoue
H
H
Takishima
T
T
D000280:Administration, Inhalation; D000403:Airway Resistance; D000818:Animals; D000941:Antigens / Q000008:administration & dosage* / Q000276:immunology; D001200:Ascaris / Q000276:immunology; D001980:Bronchi / Q000294:innervation* / Q000502:physiology; D002415:Cats; D004558:Electric Stimulation; D007114:Immunization; D007976:Leupeptins / Q000494:pharmacology; D009420:Nervous System / Q000503:physiopathology*; D009433:Neural Inhibition; D012130:Respiratory Hypersensitivity / Q000503:physiopathology*; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
D000941:Antigens; D007976:Leupeptins; D015842:Serine Proteinase Inhibitors; D014660:Vasoactive Intestinal Peptide; C032854:leupeptin